AGILE THERAPEUTICS INC
DelistedCIK 1261249fmd_0CEGA2K160ZFTAQRQ5QAP214QWManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2012 to Jun 30, 2024, 47 periods
Latest annual · FY2023
Millions- Total revenues
- 20
- Gross profit
- 11
- Operating income
- (20)
- Net income
- (14)
- Free cash flow
- (36)
Latest quarter · Q2 FY2024
Millions- Total revenues
- 6
- Gross profit
- 4
- Operating income
- (3)
- Net income
- (12)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2020 to FY2023
- +196.9%
- Revenue, 5 yearsFY2018 to FY2023
- n/m
- Net income, 5 yearsFY2018 to FY2023
- n/m
AGILE THERAPEUTICS INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Revenue | $19.6 million | $10.9 million | +80% | 10-K 2024-03-28 · proof |
| Gross profit | $10.6 million | $4 million | +162.2% | 10-K 2024-03-28 · proof |
| Operating income | -$19.9 million | -$52.6 million | 10-K 2024-03-28 · proof | |
| Net income | -$14.5 million | -$25.4 million | 10-K 2024-03-28 · proof | |
| Cash from operating activities | -$9.6 million | -$35.9 million | 10-K 2024-03-28 · proof | |
| Total assets | $10.3 million | $14.2 million | -28% | 10-K 2024-03-28 · proof |
| Total liabilities | $26.6 million | $19.8 million | +34.3% | 10-K 2024-03-28 · proof |
| Cash and cash equivalents | $2.6 million | $5.2 million | -51.3% | 10-K 2024-03-28 · proof |
| Total debt | $3 million | $2.9 million | +6.2% | 10-K 2024-03-28 · proof |
- What was AGILE THERAPEUTICS INC's revenue in fiscal 2023?
- AGILE THERAPEUTICS INC reported revenue of $19.6 million for fiscal 2023 (the year ended Dec 31, 2023), against $10.9 million the year before (+80%). Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What was AGILE THERAPEUTICS INC's gross profit in fiscal 2023?
- AGILE THERAPEUTICS INC reported gross profit of $10.6 million for fiscal 2023 (the year ended Dec 31, 2023), against $4 million the year before (+162.2%). Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What was AGILE THERAPEUTICS INC's operating income in fiscal 2023?
- AGILE THERAPEUTICS INC reported operating income of -$19.9 million for fiscal 2023 (the year ended Dec 31, 2023), against -$52.6 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What was AGILE THERAPEUTICS INC's net income in fiscal 2023?
- AGILE THERAPEUTICS INC reported net income of -$14.5 million for fiscal 2023 (the year ended Dec 31, 2023), against -$25.4 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What was AGILE THERAPEUTICS INC's cash from operating activities in fiscal 2023?
- AGILE THERAPEUTICS INC reported cash from operating activities of -$9.6 million for fiscal 2023 (the year ended Dec 31, 2023), against -$35.9 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What are AGILE THERAPEUTICS INC's total assets?
- As of Dec 31, 2023, AGILE THERAPEUTICS INC reported total assets of $10.3 million, against $14.2 million a year earlier (-28%). Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What are AGILE THERAPEUTICS INC's total liabilities?
- As of Dec 31, 2023, AGILE THERAPEUTICS INC reported total liabilities of $26.6 million, against $19.8 million a year earlier (+34.3%). Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What are AGILE THERAPEUTICS INC's cash and cash equivalents?
- As of Dec 31, 2023, AGILE THERAPEUTICS INC reported cash and cash equivalents of $2.6 million, against $5.2 million a year earlier (-51.3%). Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
- What is AGILE THERAPEUTICS INC's total debt?
- As of Dec 31, 2023, AGILE THERAPEUTICS INC reported total debt of $3 million, against $2.9 million a year earlier (+6.2%). Source: the 10-K filed with the SEC on Mar 28, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1261249&period_type=annual&limit=5"Information only, not investment advice.